Ventricular Restoration Systems Market Perspective, Comprehensive Analysis, Growth and Forecast 2020-2030

Ventricular restoration systems offers a less invasive intervention for heart failure patients. Cardiovascular diseases are on a consistent rise in countries around the world. According to WHO, cardiovascular diseases take an estimated 17.9 million lives each year and is the no. 1 cause of death worldwide.

Thus, there is an increase focus on inventing treatments that will reduce the fatalities and mortality rate caused by this diseases.

Several developments in the cardiac field has been made to provide better care. For instance, Ancora Heart initiated a U.S.-based feasibility study to evaluate the AccuCinch ventricular repair system, in May 2019. These developments will further propel augment the growth of the ventricular restoration systems market.

Ventricular Restoration Systems Market: Drivers and Restraints

The rise in no. of cardiac cases around the world is the major factor driving the growth of ventricular restoration systems market. The rising focus on healthcare across various region is another factor that is estimated to propel the growth of the ventricular restoration systems market.

In addition, rising growth in medical tourism in certain developing countries will also contribute towards the growth of the ventricular restoration systems market.

Increasing demand for innovative products and constant R&D activities carried out by the manufacturers to improve the technological aspect in these medical devices will also boost the growth of the ventricular restoration systems market. The accessibility to different medical coverage for the repayment of cardiovascular medical procedures will also contribute towards the growth of the ventricular restoration systems market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12876

However, the high cost of the ventricular restoration systems coupled with strict regulations may hamper the growth of the ventricular restoration systems market.

Ventricular Restoration Systems Market: Overview

Based on application, the percutaneous ventricular system is expected to experiences considerable growth during the forecast period owing to the minimization of the risk of a more invasive method.

In the end user segment, hospitals will continue to hold the largest share in the ventricular restoration systems market. The no. of cardiac surgeries carried out in the hospital is expected to contribute towards the continued growth of this segment. The effective in-patient and out-patient services may account for a higher market share.

Ventricular Restoration Systems Market: Regional-Wise Outlook

Geographically, the Ventricular restoration systems Market market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa.

North America is expected to hold the largest market share in the ventricular restoration systems market. This can be attributed towards high demand and adoption of the ventricular restoration systems. Moreover, this well-established healthcare system along with skilled professional will also serve as one of the major factors leading to the dominance of this region in the global ventricular restoration systems market.

The large R&D investments made by key players in this region to cater to the needs of the population also contributes towards the growth of the ventricular restoration systems market in this region.

Europe is expected to hold the 2nd largest market share owing to rising cardiovascular cases in this region. However, East Asia and South Asia is expected to experience fastest growth in the ventricular restoration systems market. The exponentially growing medical device industry in this region will lead to considerable growth of the market in this region. In addition, medical tourism in countries like India will further propel the growth of the ventricular restoration systems market in this region.

Ventricular Restoration Systems Market: Key players

Some of the players identified in the Ventricular restoration systems Market include:

  • Abott
  • Bioventrix Inc.
  • Xeltis AG
  • Neochord Inc.
  •  CryoLife Inc.
  • Edwards Lifesciences Corp.
  • CardioKinetics Inc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12876

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Boxcar Scars Market Trend 2021, Growth, Leading Companies with Impact of Covid-19, Business Scenario, Emerging Dynamics, Industry Share and Revenue Forecast by 2031

Boxcar scars are a type of acne scars which look like round, oval depression. As the scars are of different types, for example, based on redness, depth or location, its treatment also varies. Microdermabrasion, Dermabrasion, Fillers, Chemical Peels, Laser Therapy, Microneedling, Punch Excision, and Subcision, are some of the treatments required for treating boxcar scars. As these scars can’t go away of their own, People considering the treatment is growing.

Growing Preference for Micro needling and Ablative Lasers

The ablative lasers are considered as the gold standard for treating acne scars, patients have witnessed a 75% improvement in atrophic acne scars at 18 months after this high energy carbon dioxide laser treatment. The technique when used on dark skinned people showed good to excellent results in 74%, however hyper pigmentation was witnessed among 29% of patients. Due to its long time recovery process and various side effects, the ablative lasers have become less popular.

Of late, microneedling is gaining momentum as they provide the best cosmetic outcomes. Due to its collagen inducing effect, the encouraging results prove that microneedling is an effective and inexpensive method for dealing with boxcar scars. It takes very less time for recovering, a study found that only after 3 treatments, patients can visibly see the positive effect in their scarring and is relatively risk free. Microneedling can be performed with a dermaroller or a microneedling pen. Microneedling involves puncturing the skin multiple times using needles, a tattoo gun or roller. When microneedling is combined with platelet rich plasma or glycolic acid peels, improvement in acne scar improved up to 62%.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12926

Emerging Technologies May Help Boost the Boxcar Scars Market

Researchers and scientists are always on the motion of developing and introducing new and more effective treatments for replacing the traditional therapies. For instance, a latest technology for the treatment of scarring is laser speckle contrast imaging (LSCI). LSCI helps in detecting the backscatter which eventually detects the blood flow by illuminating the tissue with its coherent laser light. The technique is relevant for scarring because the healing process of scarring requires adequate tissue perfusion. LSCI can also be used to treat patients with burn wounds as it detects the severity of partial thickness in wounds.

Complications in Laser Therapy

Side effects due to laser therapy such as burns, dyspigmentation and infection may happen after the laser treatment. Laser treatment has a risk of overheating the tissue through excessive heat generation or by a failure of the cooling techniques. The risk of burns is higher for lasers that use a continuous beam. Risk of dyspigmentation is higher in dark skinned or tan individuals. Due to such side effects, the treatment by laser may go back scale. However, latest innovations in the sector may help in mitigating the issue.

Competitive Landscape

The key players in the market include

  • Merz, Inc.
  • Cerave
  • Lumenis
  • Enaltus LLC
  • Scarsheal, Inc.
  • CCA Industries
  • Proactiv Company
  • Cynosure, Inc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12926

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Folliculotropic Mycosis Fungoides Treatment Market Analysis (COVID-19 Analysis) – Industry Insights, Drivers, Top Trends, Global Analysis, Forecast and Opportunities to 2031

Folliculotropic Mycosis Fungoides (FMF), one type of cutaneous T-cell lymphoma is a rare disease in which white blood cells, namely lymphocytes become harmful or cancerous causing adverse effect on skin. Red patches on skin without any injury can be a sign of the disease. The disease is more prominent in males than in females with a ratio between 1.6 and 2. Several treatments are there but they are performed based on how severe the disease is and previous medical treatments. Treatments such as Irradiation, Photochemotherapy, using ultraviolet A, light treatment enhanced with psoralen (PUVA), photodynamic therapy, carbon dioxide laser surgery are performed. Performing surgery first has its own benefit as providing radiation to the same location at a later time preserves options for future therapy.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13012

Growing Prevalence of Radiation Therapy as a Treatment

Radiation therapy uses radiations to destroy the cancer cells. Radiation therapy can be performed to get rid of the cancerous cells entirely or to control the symptoms in severe stages. A study by Thomas et al reported that a single dose of radiation (700-800cGy) results in giving much more palliations than multiple fraction radiation treatment among patients with cutaneous T-cell lymphoma (CTCL). The International Lymphoma Radiation Oncology Group Network advices total dose of 8-12Gy to be given to patients of CTCL. According to redjournal.org, radiation therapy doses provide good clinical response and less toxicity.

Among 270 lesions on which radiation treatment was performed, 97% were treated with 700cGy of radiation. The complete response rate was among 94.4% lesions and partial response was witnessed in 3.7% of patients. Only 1 lesion showed zero response. Therefore, radiation treatment may be a good response for mycosis fungoids and thus, its demand may fuel in the treatment sector.

Effectiveness of Extracorporeal Photopheresis (ECP) may Help Grow the Folliculotropic Mycosis Fungoides Treatment Market

Many patients suffering from advanced cutaneous T-cell lymphomas may be treated by ECP. It is a painless procedure that treats the white blood cells improving the symptoms. Besides, CTCL, ECP is used for treating lung transplant rejection, heart transplant rejection, and chronic graft versus host disease. The procedure is safe and typically takes 2 hours in total. The procedure can be performed with a single piece of equipment and is easier to evaluate the quality and quantity of treated mononuclear cells. Slight side effects can be observed such as numbness or headache and eyes and skin is more sensitive to sunlight after the treatment. Moreover, ECP treatment is cost effective as compared to other treatments.

Thus, comfortable and speedy treatment plays a crucial role in encouraging the patients to adopt the procedure. Awareness regarding these treatments is another factor why the market may fuel growth.

High Cost of Treatment may Impact the Market

Chemotherapies or any other treatment for cancer is high in cost and large population of the world cannot afford that which cause deaths and may impact the Folliculotropic Mycosis Fungoides Treatment market also. For instance, an article by ncbi.nlm.nih.gov reports, phototherapy with psoralens and ultraviolet A light (PUVA) cost almost 3,187 Euros for 6 months, electron beam therapy costs around 7,913 Euros for 6 months. Also, higher incidences of the diseases are reported in Spain only.

India is also the region where a large number of population do not have health insurance and they cannot pay out of pocket medical expenses due to lack of resources. India spends only 3.89% of GDP on health care as compared to US which spends 17.8%. Thus, in developing economies, the Folliculotropic Mycosis Fungoides Treatment market may be hampered due to lack of awareness and less resources available.

Competitive Landscape

Major companies in the global Folliculotropic Mycosis Fungoides Treatment Market are

  • Astellas Pharma, Inc
  • Bayer AG
  • Novartis AG
  • Pfizer Inc
  • Merck Co., Inc.
  • GlaxoSmithKline plc
  • Abbott, Mylan N.V, etc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13012

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

ENT Endoscopy Market 2021 (COVID-19 Impact Analysis Included) Opportunities, Regional Overview, Top Leaders, Revenue and Forecast to 2031

“ENT endoscope” is a tubular device that is used in a minimally invasive medical diagnostic procedure called “ENT endoscopy” where an organ’s internal surface can be assessed. As per the latest research, the ENT Endoscopy Market is forecasted to experience exponential growth during 2021-2031. The Global market for ENT endoscopy is expected to grow at a CAGR of a big percentage in the forecast period (2021-2031).

What is Driving Demand for ENT endoscopy?

Essential drivers of the ENT endoscopy market are diseases like sinusitis and fast advancement in medical technology. In 2020, surgeries like Endoscopic sinus surgery, neurosurgery, skull-based surgery, and sales of other endoscopy devices led to the surpassing of endoscopic market size and giving it a benefit as compared to the previous years. The sales of ENT endoscopy went through a good growth phase, leading to crucial challenges that are to be faced by manufacturers but the market is expected to gain momentum in the forecast period since there are great medical and technological advancements taking place widely.

The high prevalence of Chronic Sinusitis is one of the major drivers of the endoscopy market, lead to the inflow of patients in hospitals and ENT clinics which in turn lead to the increase of production of ENT tools leading to the gross profit of the entire market. It demonstrates that the Endoscopy market can be interdependent on other markets and the profits can go hand in hand.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13159

What is the Repercussion of the Pandemic on the Growth of the ENT Endoscopy Market?

Due to the Covid-19 pandemic, the ENT endoscope market got affected badly as the endoscopic services were under secondary procedures which were to be shut down but the sales of ENT tools were actively done in the Medical and Healthcare sectors during the treatment of COVID-19 positive patients which kept a stable momentum of the market. Yet, an analytics firm “GlobalData” predicts a heavy surge in the ENT endoscopy market sales in 2021 and in the forecast period (2021-2031) after facing a huge number of losses in previous years.

The US and Canada ENT endoscopy Market Outlook

A good growth rate of the ENT endoscopy market is expected to expand for the US due to an increase in the number of endoscopic procedures performed all around the region, any of the incident and prevalent ENT related disorders like an Ear infection (Otis media), Gastric reflux, dizziness, Dysphagia (difficulty swallowing) and Hearing loss lead to the skyrocketing of the ENT endoscopy market since more and more advancements are being done for the production of the ENT tools.

The Canadian endoscopy market on the other hand is also expected to grow with good and steady growth but comparatively lesser than that of the American market. Endoscopic ear surgery which is a new technique and surgery with fast recovery with lesser post-surgical infections is in high demand due to which these turn out to be the driving factors of the ENT endoscopy market.

Europe Demand Outlook for ENT endoscopy 

Major drivers of Ent endoscopy market in the European region (Germany, UK, France, Spain, and Italy) prevalence of ENT related disorders like chronic rhinosinusitis, Hearing loss, gastric reflux, and Dysphagia. Germany dominated the European market making the highest gross value when compared with other European companies.

As per a statistical analysis done by World Allergy Organization (WAO), chronic rhinosinusitis’s disease prevalence ranged from 11% in Europe due to which led to an increase in the sales of the ENT endoscopy market which will result in the market’s expansion and is expected to grow even more in the forecast period.

Who are the Key Manufacturers and Suppliers of ENT endoscopy?

Top leading manufacturers and suppliers of ENT endoscopy include

  • Olympus
  • Pentax
  • Fujifilm
  • Karl Storz
  • Arthrex
  • Boston Scientific
  • Conmed
  • Cook Medical
  • Covidien

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13159

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Pain Patches Market Size, Growth Opportunities, Industry Potential, Segmentation Overview, Trends And Forecast Studies 2031

According to latest research by Future Market Insights, Pain Patches Market will experience substantial growth during the forecast period 2021-2031. Demand for pain patches will elevate in the course of forecast period while experiencing a steady growth. Increased demand pain patches to encounter the pain resulted from various medical conditions represents lucrative growth for pain patches market.

What is Driving Demand for Pain Patches?

Pain patch is a medicated adhesive patch that is used to relieve the pain by placing it on the skin. Pain patch uses a transdermal route and therefore provides an advantage of controlled delivery of medication as compared to other routes of administration. This advantage may result in increasing the sales of pain patches during the forecast period.

Increasing number of accidents that result in severe injury is expected to drive the growth of pain patches market across the globe. According to the Association for Safe International Travel, in 2020, approximately 4.4. million individuals were severely injured to require medical attention in the U.S. Moreover, increasing number of sports related injuries will also lead to a rise in demand for pain patch market.

In addition, changes in lifestyle and emergence of more office related jobs that needs continuous sitting in one position for too long may result in back related ailments among others. This will also lead to significant growth in the pain patches market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13194

Increasing Prevalence of Arthritis Expected to Augment the Growth of Pain Patches Market

Increasing chronic and acute pain related diseases is expected to reflect a positive growth for pain patches market. One such disease is arthritis which results in severe joint pain. The increasing prevalence of arthritis mainly is expected to increase the demand for pain patches. According to CDC, in 2018, an estimated 22.7% of the U.S. population of adults had doctor diagnosed arthritis.

U.S. and Canada Pain Patches Market Outlook

U.S. and Canada are among the largest market for pain patches market making North America a dominant player. The adoption of transdermal pain patches has increased in North America for pain management of certain conditions, which includes cancer. Pain patches are quite effective as compared to pain killers as they deliver pain management drugs at a predetermined rate across the dermis and achieve a local or a systemic effect.

This indicates that high prevalence of cancer will lead to rise in demand for pain patches market. According to National Cancer Institute, in 2018 an estimated 16,353,421 people living with cancer of any site in the U.S.

Europe Demand Outlook for Pain Patches

Increasing usage of pain patches for pain management for non-cancer conditions is expected to drive the growth of the pain patches market in this regions. Additionally, the increasing research and development funding and increasing focus of the European governments on the healthcare system also represents steady growth for pain patches market.

Moreover, favourable reimbursement policies in many European countries will also boost further growth of the pain patches market.

Who are the Key Manufacturers and Suppliers of Pain Patches?

Some of the leading manufacturers operating in the pain patches market include

  • Viatris, Inc.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Hisamitsu Pharmaceutical Co., Inc.
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Nichiban Co., Ltd.
  • Teikoku Seiyaku Co, Ltd.
  • Mentholatum Company.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13194

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

3D Printed Medical Devices Market is projected for stupendous growth at 16% CAGR during 2021- 2029 and value of over US$ 440 Million

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.
The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2019 – 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.
The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Key Takeaways – 3D Printed Medical Devices Market Study

• Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
• PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
• Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
• The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

To remain ‘ahead’ of your competitors, request for a sample

3D PRINTED MEDICAL DEVICES MARKET STRUCTURE ANALYSIS

• Key players are focusing on strengthening their position by establishing new facilities in North America. In order to increase their revenue share, major players in North America are entering into agreements with hospitals and academic institutes.

• Various manufacturers are targeting Asia and Europe through distribution agreements with local players.

• Some of the key players in the 3D printed medical devices market include

1. 3D Systems, Inc.,
2. EnvisionTEC, and
3. EOS GmbH Electro Optical Systems among others.

• Large medical device manufacturers are increasingly gaining interest in 3D technology for manufacturing. These medical device companies are thus investing in 3D technology through acquisitions. For an instance, GE Healthcare acquired 95% of share of Arcam AB in December 2017.

Learn More About Report Inclusions
Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1501

3D PRINTED MEDICAL DEVICES MARKET TAXONOMY

FMI’s study on the 3D printed medical devices market offers information divided into five important segments – application, material type, technology, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Application

  • Orthopedic Implants
  • Dental Implants
  • Carnio-Maxillofacial Implant

Material Type

  • Metals and Alloys
  • Biomaterial Inks
  • Plastics

Technology

  • Stereolithography (SLA) – Liquid-based 3D Printing
  • Selective Layer Sintering (SLS) – Powder-based 3D Printing
  • Digital Light Processing(DLP)
  • Fused Deposition Modelling (FDM)-Plastic Filament Extrusion-based
  • PolyJet – InkJet 3D Printing
  • Electronic Beam Melting (EBM)

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • JAPAN
    • Middle East and Africa

For in-depth insights, Download a PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

Anaesthesia Machines Market Key Players – GE Healthcare, Drägerwerk AG & Co. KGaA, Heyer Medical AG, Infinium Medical, Inc., ACOMA Medical Industry Co., Ltd.

Mergers and Collaborations to Present High Growth Opportunities for Market Players in the Coming Years

Mergers and collaborations between local and international players in developing regions are expected to present potential opportunities for growth in terms of successful market penetration and sales. The regional markets of Asia Pacific, Latin America and GCC countries is anticipated to create significant opportunities to players involved in anaesthesia machines market. This can be attributed to the increasing surgical procedures in these regions coupled with increasing per capita expenditure on cosmetic surgeries and other healthcare associated procedures. Players in this market are establishing business relationships with healthcare facilities in these regions as well as government agencies for long term gains and enhancing their presence in the region. Moreover, partnership programs between organizations and institutions are observed to facilitate anaesthesia training programs.

The research report “Anaesthesia Machines Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” published by Future Market Insights throws light on several aspects driving the global market. The growth of the market is impacted by various trends, developments, drivers and challenges, the analysis of which is included in the fact based research report. The exhaustive research publication covers historical data analysis along with current scenario as well as future projections of the market from a value standpoint for a 10 year period, starting from 2017 till 2027. The analysis on various segments playing a major role in the expansion of the global anaesthesia market has been carried out to get a complete picture of the global market.

To remain ‘ahead’ of your competitors, request for a sample

Top Players Competing in the Global Anaesthesia Machines Market

The research report includes profiles of major players operating in the anaesthesia machines market. To name a few, the report includes intelligence on players such as

  • GE Healthcare
  • Drägerwerk AG & Co.
  • KGaA, Mindray Medical International Limited
  • Getinge AB
  • Spacelabs Healthcare
  • Heyer Medical AG
  • Infinium Medical, Inc.
  • ACOMA Medical Industry Co., Ltd.
  • Chirana Medical A.S.
  • DRE Medical
  • BPL Medical Technologies
  • Beijing Aeonmed Co. Ltd.
  • Comen Medical Instruments Co. Ltd.
  • Okuman Medical System Ltd.
  • Narang Medical Limited
  • Lowenstein Medical GmbH & Co.

Increasing Need for Anaesthesia Procedures to Spur the Adoption of Anaesthesia Machines in the Coming Years

According to WHO (World Health Organization) and World Bank, by 2026, the treatments demanding surgeries and hence anaesthesia machines would eclipse that of tuberculosis and HIV as well as malaria. Current market scenario portrays the fact that about 30% of the population in the entire globe do not have access to surgeries. On the contrary, about 75% of major procedures are being performed in the wealthiest countries in the world whereas poor countries are witnessing only 3.5% of operations. Government bodies along with non-government institutions are continuously working on offering healthcare access to every region, which is expected to trigger the adoption of anaesthesia machines. The growing number of surgeries and increasing government support are expected to fuel the growth of the anaesthesia machines market at a global level in the years to follow.

Global Market for Anaesthesia Machines: Factors Promoting Growth

The global market for anaesthesia machines is influenced by several aspects that facilitate the growth of the global market. Few of these aspects include continual technological advancements in anaesthesia machines, integration of IT in healthcare systems pushing the demand for anaesthesia workstations, emergence of anaesthesia information management systems, increasing public and private investments in healthcare, expanding imports and exports of medical devices among different regions, expanding private sector, enhancement in product lines by various manufacturers of anaesthesia machines, growing trend of patient monitoring using IoT, favourable government support, increasing medical tourism, growing geriatric population and manufacturing of cost effective anaesthesia machines.

However, product recalls due to defects in devices, shortage of healthcare professionals, adoption of refurbished machines, lack of public access to healthcare facilities and lack of clinical resources are expected to pose hindrances to the growth of the global market.

Segmental Highlights on the Anaesthesia Machines Market

  • With respect to region, North America and Asia Pacific excluding Japan (APEJ) are expected to showcase high potential for growth. Anaesthesia machines market in North America (led by US) is estimated to be the largest, whereas the market in APEJ is expected to rise at a comparatively high value CAGR during the forecast period
  • With respect to modality, the standalone anaesthesia machines are expected to witness increased adoption across the globe in several hospitals and clinics. This segment is expected to lead the global market with a high valuation and projected to expand at a relatively high CAGR throughout the period of assessment

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-789

Key Segments Covered

By Modality

  • Standalone Anaesthesia Machines
  • Portable Anaesthesia Machines

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-789

By End User

  • Hospitals
  • Surgical Ambulatory Centres
  • Clinics
  • Nursing Facilities

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East and Africa (MEA)

Arthroscopy Procedures and Products Market is poised to expand at over 7.7% CAGR and Reach Almost US$ 6.48 Billion During 2021–2031

ESOMAR-certified consulting firm Future Market Insights, in its updated report, projects a steady growth of the arthroscopy procedures and products market between 2021 and 2031. The market is expected to reach a valuation of approx. US$ 6488.4 Mn in 2021.

Due to the non-invasive nature and benefits of arthroscopy, patients suffering from severe osteoarthritis are preferring knee arthroscopy, which is accelerating the market growth.

Rising prevalence of knee osteoarthritis among geriatric population and increasing number of knee arthroscopy conducted worldwide have augmented the market growth. Increasing application in sports medicine, and ease in regulatory approval such as the U.S. Food & Drug Administration are the factors driving growth.

Growing incidence of osteoarthritis across the U.S., Germany, the UK, and China have propelled the adoption of knee arthroscopy surgeries in those regions.

With such rising statistics, healthcare professionals and government are increasing the initiatives to provide rehabilitation and facilities to curb the additional cost. Based on such factors, the market is anticipated to witness healthy growth at over 7.7% CAGR during 2021 and 2031.

However, increasing risk of edema and other infections such as blood clots in the joints might restrict the market growth. Also, high cost of surgery and procedures across low economies such as Brazil, India and other countries in Latin America will hamper the market growth.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1386

Key Takeaways from FMI’s Arthroscopy Procedures and Products Market Study

  • In terms of procedure type, knee arthroscopy will account for over 50% of the global market share
  • Arthroscopic implants segment will account for highest share of the arthroscopy procedures & products market during the forecast period
  • The U.S. will emerge as the most lucrative market backed by the rising prevalence of degenerative disease among geriatric population
  • Germany and the U.K., collectively, will emerge as the most lucrative market across Europe in the upcoming decade
  • Japan is anticipated to emerge as a lucrative market backed by the high prevalence of rheumatoid arthritis and osteoarthritis among elderly

Competitive Landscape

Prominent players in the market are focusing on strategic mergers and collaboration to expand their global footprint in the market.

New product launches coupled with increasing research & development activities for the development of advanced arthroscopy instruments & devices will also be one of the key strategy to enhance their customer base for market players.

For instance, couple of years back, leading player, Smith & Nephew entered into a distribution agreement with OrthAlign, a U.S. based private company to develop medical devices and distribute their Total-Knee Arthroplasty (TKA) technology across several countries in Africa and Middle East.

Also, in 2018, Ceterix® Orthopedics, Inc., a leader in the development of cutting-edge surgical tools for orthopedic surgeons announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears for arthroscopic surgeries.

Key Players

  • Arthrex Inc.
  • CONMED Corporation
  • Johnson & Johnson
  • KARL STORZ GmbH & Co. KG
  • Olympus Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1386

More Insights on the Global Arthroscopy Procedures and Products Market

In its new offering, Future Market Insights, offers incisive coverage on global arthroscopy procedures and products market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is classified on the basis of products type (arthroscopes & visualization systems, arthroscopic resection systems, arthroscopic fluid management systems, arthroscopic implants, arthroscopy radiofrequency (RF) systems, arthroscopic drills & fixation systems, and others), and procedure type (shoulder arthroscopy, hip arthroscopy, knee arthroscopy, elbow arthroscopy, small joints arthroscopy, and others) across major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

Key Points Covered in Arthroscopy Procedure and products Market Study

  • Market estimates and forecast 2021-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Arthroscopy Procedure and products tools market and How to Navigate
  • Recommendation on Key Winning Strategies

Arthroscopy Procedure and Product Market by Category

By Product Type:

  • Arthroscopes and Visualization Systems
  • Arthroscopic Resection Systems
  • Arthroscopic Fluid Management Systems
  • Arthroscopic Implants
    • Knee Implants
    • Shoulder Implants
    • Hip Implants
    • Other Implants
  • Arthroscopy Radiofrequency (RF) Systems
  • Arthroscopic Drills and Fixation Systems
  • Other Arthroscopy Instruments and Accessories

By Procedure Type:

  • Shoulder Arthroscopy
  • Hip Arthroscopy
  • Knee Arthroscopy
  • Elbow Arthroscopy
  • Small Joints Arthroscopy
  • Others

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1386

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Light Therapy Market is likely to surpass US$ 1 billion in the short-run, expanding at a moderate CAGR in Forecast Period 2021-2031

[263 Pages Report] According to FMI’s estimates, the Light Therapy Market is expected to perform significantly well in the short-run forecast period, surpassing US$ 1 billion by the first half of this decade. It is apprehended that the global burden of depression is expected to double by 2030. Hence, immense growth opportunities are in store for prominent light therapy providers.

As per FMI’s report, growth prospects are likely to emerge across skin and insomnia treatment domains as well. With at least one to three out of ten people experiencing disrupted sleep cycles, patients are seeking effective therapeutic approaches, thereby widening growth prospects. Furthermore, skin ailments contribute to almost 2% of the global burden of disorders.

ESOMAR certified market research company Future Market Insights (FMI) global light therapy market is likely to surpass US$ 1 billion in the short-run, expanding at a moderate CAGR in that time period. Long-term prospects appears largely optimistic, with credible opportunities expected to present themselves with respect to addressing acute depression problems.

Manufacturers are primarily emphasizing on introducing portable and lightweight handheld light therapy devices amid the rising demand for flexible therapeutic solutions. For instance, the LightStim For Wrinkles is an award-winning FDA-cleared red light therapy device for skincare, deploying a patented multi-wave technology based on advanced LED technology from NASA. Likewise, the iRestore Laser Hair Growth System for treating androgenic alopecia deploys a 650 mm wavelength red light which is clinically proven to enhance hair growth.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1160

Key Takeaways from FMI’s Light Therapy Market Study

  • By product, handheld light therapy devices for skin treatment are likely to enjoy highest demand
  • By light type, demand for red light therapy is expected to reach new heights, characterized by increasing numbers of clinical trials
  • By end-user, dermatological centers are expected to be primary light therapy treatment centers in forthcoming years
  • High seasonal affective disorder (SAD) incidence fueling light therapy treatment in the US
  • UK to attract high investments, characterized by the presence of prominent phototherapy light manufacturers
  • Germany to generate lucrative growth prospects amid extensive applications across the photodynamic treatment (PDT) segment
  • Surging dermatological problems to widen natural treatment approaches scope in India, widening prospects for light therapy

Competitive Landscape

Koninklijke Philips N.V., Verilux Inc., Northern Light Technology, Sphere Gadget Technologies, Zepter International, PhotoMedex Inc., Luminette, Klarstein, Lumie and Aura Daylight are some prominent light therapy market players profiled by FMI’s report on the landscape.

Offering new products based on the latest technology is the primary strategy deployed by a majority of the aforementioned market players. For instance, Klarstein offers its 3MC light therapy sunlight SAD disorder lamp for medical purposes. This product is especially suitable for treating for treating seasonal affective disorder by deploying a mid-day simulating spectrum.

In September 2019, Lumie launched the Bodyclock Luxe 700FM and Bodyclock Luxe 750DAB wake up lights. These are class-I medical devices which offer high quality light and audio experience for easier sleep and brighter waking. These clocks are tuned to reflect day time patterns which helps regulate sleep to improve mood, energy, productivity and sleep quality.

light therapy market characteristics and attributes with regional relevence, 2021-2031

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1160

Light Therapy Market by Category

By Product

  • Light Box
  • Floor and Desk Lamps
  • Light Visor
  • Dawn Simulator
  • Light Therapy Bulbs

By Light Type

  • White Light
  • Blue Light
  • Red Light

By End User

  • Dermatology Clinics
  • Homecare Settings
  • Others (Workplace, Salons)

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1160

By Region

  • North America
  • Latin America
  • APEJ
  • Western Europe
  • Eastern Europe
  • Middle East & Africa
  • Japan

Peptide therapeutics Market Key Players- AstraZeneca plc., Eli Lilly and Company, Merck & Co. Inc., Novo Nordisk A/S., Teva Pharmaceutical Industries Ltd

The global peptide therapeutics market was valued at US$ 25.6 Billion in 2019, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2020-2030).

Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases. Rising prevalence of these chronic diseases across the world is further expected to widen the existing patient pool. Therapeutic efficacy of peptide therapeutics is relatively superior as compared to other marketed drugs, resulting in their higher adoption among physicians.

The COVID-19 pandemic has been severely affecting the global economic order, and, in turn, the peptide therapeutics market. Restrictions on traveling, self-quarantines, and social distancing regulations, on a national scale, are resulting in notable drop in business and consumer spending through Q2.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1038

“Higher efficacy, widespread availability, and future generic competition are amongst the key factors expected to shape the peptide therapeutics market across the world. With increasing regional product adoption in Asia Pacific (APAC) and the Middle East & Africa (MEA), market players are driving their attention towards these regions for sustained growth.””

Key Takeaways of Peptide Therapeutics Market Study

  • In terms revenue generation, among the applications, cancer outperformed other application types, owing to greater prevalence of the disease as well as higher efficacy of peptide therapeutics in cancer treatment.
  • Various peptide therapeutics are patented, and, in the mid of this decade, a majority of these patents are expected to reach their expiry dates, leading to higher generic competition.
  • Parenteral route continues to hold the leading revenue share in the peptide therapeutics market, owing to effective drug delivery and higher therapeutic index.

Key Players Focus on Strategic Collaborations and Generic Launches to Widen Regional PresenceLeading players in the peptide therapeutics market, such as AstraZeneca plc, Merck Co. & Inc., and Elli Lily, are concentrating on business expansions through joint ventures and distribution agreements, and are capturing untapped market potential.

Additionally, market incumbents are entering into collaborations in order to expand their regional presence and manufacturing capabilities in the global peptide therapeutics market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1038

Peptide Therapeutics Market by Route of Administration

More Valuable Insights on Peptide Therapeutics Market Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2015 to 2030. The global peptide therapeutics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the peptide therapeutics market on the basis of application, (cancer, cardiovascular diseases, central nervous systems, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, dermatology, respiratory disorders, acromegaly, and other applications), route of administration (parenteral route, mucosal

Key Companies Profiled

  • Novo Nordisk A/S.
  • Teva Pharmaceutical Industries Ltd

route, oral route, and transdermal route), and marketing (branded and generic), across seven major regions.

The global peptide therapeutics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers.

Application

  • Cancer
  • Cardiovascular Diseases
  • Central Nervous Systems
  • Metabolic Disorders
  • Infections
  • Hematological Disorders
  • Gastrointestinal Disorders
  • Dermatology
  • Respiratory Disorders
  • Acromegaly
  • Other Applications

Route of Administration

  • Parenteral Route
  • Mucosal Route
  • Oral Route
  • Transdermal Route

Marketing

  • Branded
  • Generic

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1038

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • MEA
  • Japan